Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
JMIR Medical Informatics|February 4, 2026
Linking Electronic Health Records for Multiple Sclerosis Research: Comparative Study of Deterministic, Probabilistic, and Machine Learning Linkage MethodsOhoud Almadani, Yasser Albogami, Adel AlrwisanSaudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|July 26, 2021
Covid-19 Vaccine Surveillance in Saudi Arabia: Opportunities for Real-time AssessmentYasser Albogami, Hadeel Alkofide, Adel AlrwisanSaudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|September 28, 2017
Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi ArabiaIbrahim Sales, Hisham Aljadhey, Yasser Albogami, et al.BMC Medical Research Methodology|February 21, 2023
Concordance of neonatal critical condition data between secondary databases: Florida and Texas birth certificate Linkage with medicaid analytic extractYasser Albogami, Yanmin Zhu, Xi Wang, et al.Pharmacoepidemiology and Drug Safety|October 17, 2021
Generalizability and accuracy of IBM MarketScan health risk assessment instrument data for augmentation of commercial claims dataYasser Albogami, Yu-Jung J Wei, Almut G WintersteinSurgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 2, 2021
Evaluation of statin discontinuation stratified by primary versus secondary prevention following bariatric surgery: a retrospective cohort studyAbdulrahman Alsuhibani, Yasser Albogami, Vakaramoko Diaby, et al.Drug Safety|March 8, 2021
Real-World Fetal Exposure to Acne Treatments in the United States: A Retrospective Analysis from 2006 to 2015Yasser Albogami, Amir Sarayani, Juan M Hincapie-Castillo, et al.Journal of Infection and Public Health|October 23, 2023
The effectiveness of single and two-dose Pfizer-BioNTech vaccine against SARS-COV-2: A real-world evidence from Saudi ArabiaYasser Albogami, Abdulaziz Alalwan, Mohammed A Batais, et al.Diabetes Research and Clinical Practice|July 6, 2024
Treatment modification patterns of glucose-lowering agents in Saudi Arabia: A retrospective real-world data analysisAlmaha Alfakhri, Ohoud Almadani, Turki Althunian, et al.Pharmacoepidemiology and Drug Safety|January 6, 2026
The Risk of Hypothyroidism With the Use of GLP-1 Receptor Agonists in Saudi ArabiaAlmaha Alfakhri, Ohoud Almadani, Raseel Alroba, et al.Pageof 3